Marijuana - Public Weed Stocks & Analysis

[SamL67]

Recent news by first company in article-imlff. Just appointed the Vp of finance for investments from Eli Lilly to their board--this could be the potential strategic investment they will Need to move forward with clinical trials. Canadian based so no US schedule one issues for now. Do your own dd, but I am focused on preclinical stage companies utilizing the medical-pharmacological properties of cannabaloids--and soon big pharma will too! Just started a position in owcp--teva seems to be watching that one closely.
http://finance.yahoo.com/news/inmed-pharmaceuticals-appoints-martin-bott-213600273.html;_ylt=A0LEV0hbZ3tYacQAoiTBGOd_;_ylu=X3oDMTEzbTRvcG83BGNvbG8DYmYxBHBvcwMxBHZ0aWQDVFBSREMwXzEEc2VjA3Ny
Sam